Borderline Resectable Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Borderline Resectable Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer [Phase 2]
Phase 2 trial of NIS793 in combination with FOLFIRINOX for pancreatic cancer was terminated, with results posted on 2024-07-16.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant CAN-2409 with chemoradiation or SBRT for borderline resectable pancreatic adenocarcinoma; status ACTIVE…